Table of Content

1 Molecular Diagnostics Point of Care Market Introduction and Overview
1.1 Molecular Diagnostics Point of Care Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Molecular Diagnostics Point of Care Industry Dynamic Analysis
1.5.1 Molecular Diagnostics Point of Care Market Trends Analysis
1.5.2 Molecular Diagnostics Point of Care Market Drivers Analysis
1.5.3 Molecular Diagnostics Point of Care Market Challenges Analysis
1.5.4 Molecular Diagnostics Point of Care Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Molecular Diagnostics Point of Care Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Molecular Diagnostics Point of Care Revenue and Share by Type
3 Global Molecular Diagnostics Point of Care Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Molecular Diagnostics Point of Care Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Molecular Diagnostics Point of Care Market Size (2018-2023)
4.2 Molecular Diagnostics Point of Care Growth Insights by Regions
4.2.1 Molecular Diagnostics Point of Care Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Molecular Diagnostics Point of Care Revenue Market Size by Regions (2018-2023)
4.2.3 North America Molecular Diagnostics Point of Care Market Size (2018-2023)
4.2.4 Europe Molecular Diagnostics Point of Care Market Size (2018-2023)
4.2.5 Asia-Pacific Molecular Diagnostics Point of Care Market Size (2018-2023)
4.2.6 Latin America Molecular Diagnostics Point of Care Market Size (2018-2023)
4.2.7 Middle East & Africa Molecular Diagnostics Point of Care Market Size (2018-2023)
5 North America
5.1 North America Molecular Diagnostics Point of Care Revenue by Countries
5.1.1 North America Molecular Diagnostics Point of Care Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Molecular Diagnostics Point of Care Revenue by Countries
6.1.1 Asia Pacific Molecular Diagnostics Point of Care Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Molecular Diagnostics Point of Care Revenue by Countries
7.1.1 Europe Molecular Diagnostics Point of Care Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Molecular Diagnostics Point of Care Revenue by Countries
8.1.1 Latin America Molecular Diagnostics Point of Care Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Molecular Diagnostics Point of Care Revenue by Countries
9.1.1 Middle East & Africa Molecular Diagnostics Point of Care Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Molecular Diagnostics Point of Care Market Competition, by Players
10.1 Global Molecular Diagnostics Point of Care Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Molecular Diagnostics Point of Care Players Market Share in 2022
10.2.2 Top 6 Molecular Diagnostics Point of Care Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Molecular Diagnostics Point of Care Players Head Office, Business Provided
10.4 Molecular Diagnostics Point of Care Mergers & Acquisitions
10.5 Molecular Diagnostics Point of Care New Entrants and Expansion Plans
11 Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Profile
11.1.2 Molecular Diagnostics Point of Care Product Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.1.4 Abbott Laboratories Business Overview
11.1.5 Recent Developments and Plans
11.2 Abaxis
11.2.1 Abaxis Company Profile
11.2.2 Molecular Diagnostics Point of Care Product Overview
11.2.3 Abaxis Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.2.4 Abaxis Business Overview
11.2.5 Recent Developments and Plans
11.3 Bayer Healthcare
11.3.1 Bayer Healthcare Company Profile
11.3.2 Molecular Diagnostics Point of Care Product Overview
11.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.3.4 Bayer Healthcare Business Overview
11.3.5 Recent Developments and Plans
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Profile
11.4.2 Molecular Diagnostics Point of Care Product Overview
11.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.4.4 Bio-Rad Laboratories Business Overview
11.4.5 Recent Developments and Plans
11.5 Becton Dickinson and Company
11.5.1 Becton Dickinson and Company Company Profile
11.5.2 Molecular Diagnostics Point of Care Product Overview
11.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.5.4 Becton Dickinson and Company Business Overview
11.5.5 Recent Developments and Plans
11.6 Binx Health
11.6.1 Binx Health Company Profile
11.6.2 Molecular Diagnostics Point of Care Product Overview
11.6.3 Binx Health Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.6.4 Binx Health Business Overview
11.6.5 Recent Developments and Plans
11.7 BioMerieux
11.7.1 BioMerieux Company Profile
11.7.2 Molecular Diagnostics Point of Care Product Overview
11.7.3 BioMerieux Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.7.4 BioMerieux Business Overview
11.7.5 Recent Developments and Plans
11.8 Co-Diagnostics
11.8.1 Co-Diagnostics Company Profile
11.8.2 Molecular Diagnostics Point of Care Product Overview
11.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.8.4 Co-Diagnostics Business Overview
11.8.5 Recent Developments and Plans
11.9 DanaherCorporation
11.9.1 DanaherCorporation Company Profile
11.9.2 Molecular Diagnostics Point of Care Product Overview
11.9.3 DanaherCorporation Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.9.4 DanaherCorporation Business Overview
11.9.5 Recent Developments and Plans
11.10 Dako
11.10.1 Dako Company Profile
11.10.2 Molecular Diagnostics Point of Care Product Overview
11.10.3 Dako Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.10.4 Dako Business Overview
11.10.5 Recent Developments and Plans
11.11 F. Hoffmann
11.11.1 F. Hoffmann Company Profile
11.11.2 Molecular Diagnostics Point of Care Product Overview
11.11.3 F. Hoffmann Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.11.4 F. Hoffmann Business Overview
11.11.5 Recent Developments and Plans
11.12 OraSure Technologies
11.12.1 OraSure Technologies Company Profile
11.12.2 Molecular Diagnostics Point of Care Product Overview
11.12.3 OraSure Technologies Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.12.4 OraSure Technologies Business Overview
11.12.5 Recent Developments and Plans
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Profile
11.13.2 Molecular Diagnostics Point of Care Product Overview
11.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.13.4 Roche Diagnostics Business Overview
11.13.5 Recent Developments and Plans
11.14 Nipro Diagnostics
11.14.1 Nipro Diagnostics Company Profile
11.14.2 Molecular Diagnostics Point of Care Product Overview
11.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.14.4 Nipro Diagnostics Business Overview
11.14.5 Recent Developments and Plans
11.15 Genestat
11.15.1 Genestat Company Profile
11.15.2 Molecular Diagnostics Point of Care Product Overview
11.15.3 Genestat Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.15.4 Genestat Business Overview
11.15.5 Recent Developments and Plans
11.16 Meridian Bioscience
11.16.1 Meridian Bioscience Company Profile
11.16.2 Molecular Diagnostics Point of Care Product Overview
11.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.16.4 Meridian Bioscience Business Overview
11.16.5 Recent Developments and Plans
11.17 Molbio Diagnostics
11.17.1 Molbio Diagnostics Company Profile
11.17.2 Molecular Diagnostics Point of Care Product Overview
11.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.17.4 Molbio Diagnostics Business Overview
11.17.5 Recent Developments and Plans
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Profile
11.18.2 Molecular Diagnostics Point of Care Product Overview
11.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.18.4 Siemens Healthcare Business Overview
11.18.5 Recent Developments and Plans
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Profile
11.19.2 Molecular Diagnostics Point of Care Product Overview
11.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.19.4 Thermo Fisher Scientific Business Overview
11.19.5 Recent Developments and Plans
11.20 Visby Medical
11.20.1 Visby Medical Company Profile
11.20.2 Molecular Diagnostics Point of Care Product Overview
11.20.3 Visby Medical Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.20.4 Visby Medical Business Overview
11.20.5 Recent Developments and Plans
11.21 Wuhan Easy Diagnosis Biomedicine
11.21.1 Wuhan Easy Diagnosis Biomedicine Company Profile
11.21.2 Molecular Diagnostics Point of Care Product Overview
11.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.21.4 Wuhan Easy Diagnosis Biomedicine Business Overview
11.21.5 Recent Developments and Plans
11.22 Beijing Tiandz
11.22.1 Beijing Tiandz Company Profile
11.22.2 Molecular Diagnostics Point of Care Product Overview
11.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.22.4 Beijing Tiandz Business Overview
11.22.5 Recent Developments and Plans
11.23 Beijing Content
11.23.1 Beijing Content Company Profile
11.23.2 Molecular Diagnostics Point of Care Product Overview
11.23.3 Beijing Content Molecular Diagnostics Point of Care Market Performance (2018-2023)
11.23.4 Beijing Content Business Overview
11.23.5 Recent Developments and Plans
12 Global Molecular Diagnostics Point of Care Forecast Market Insights by Type
12.1 Global Molecular Diagnostics Point of Care Revenue Market Forecast by Type (2023-2029)
13 Global Molecular Diagnostics Point of Care Forecast Market Insights by Application
13.1 Molecular Diagnostics Point of Care Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Molecular Diagnostics Point of Care Forecast Market Size (2023-2029)
14.2 Molecular Diagnostics Point of Care Growth Forecast Insights by Regions
14.2.1 Molecular Diagnostics Point of Care Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Molecular Diagnostics Point of Care Forecast Market Size (2023-2029)
14.2.3 Europe Molecular Diagnostics Point of Care Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Molecular Diagnostics Point of Care Forecast Market Size (2023-2029)
14.2.5 Latin America Molecular Diagnostics Point of Care Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Molecular Diagnostics Point of Care Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer